NasdaqGS - Nasdaq Real Time Price USD

Sana Biotechnology, Inc. (SANA)

Compare

1.7600

+0.2300

+(15.03%)

At close: April 11 at 4:00:01 PM EDT

1.7500

-0.01

(-0.57%)

After hours: April 11 at 7:55:35 PM EDT

Monogram Technologies And Two More Penny Stocks To Watch

As the U.S. stock market rebounds from a recent downturn, with major indices like the Dow Jones and S&P 500 showing signs of recovery, investors are keenly observing potential opportunities across various sectors. Penny stocks, often associated with smaller or emerging companies, continue to capture interest despite being considered a niche investment area today. By focusing on those with strong financial health and clear growth prospects, these stocks can present unique opportunities for...

Simply Wall St. 24 days ago

SES

SES-WS

SANA
+15.03%
Sana: Q4 Earnings Snapshot

SEATTLE (AP) — Sana Biotechnology Inc. SANA) on Monday reported a loss of $49.1 million in its fourth quarter. The Seattle-based company said it had a loss of 21 cents per share.

Associated Press Finance 25 days ago

SANA
+15.03%
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome autoimmune and allogeneic immune recognition, function, and persist with stable C-peptide production post-transplant Enrolling patients in the GLEAM trial for SC291 in B-cell mediated autoimmune diseases and VIVID trial for SC262 in relapsed/refractory B-cell m

GlobeNewswire 25 days ago

SANA
+15.03%
Is Sana Biotechnology (SANA) Among Jeff Bezos’ Investments in 2025?

We recently compiled a list of the Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In. In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other companies Bezos is investing in. Since leaving his position as CEO of Amazon in 2021, Jeff Bezos has […]

Insider Monkey last month

SANA
+15.03%
Why Sana Biotechnology, Inc. (SANA) is Skyrocketing So Far in 2025

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other biotech stocks. No matter the market environment, you’ll always find entertainment in the biotech space. There will always be […]

Insider Monkey last month

SANA
+15.03%
SANA Gears Up to Report Q4 Earnings: What's in the Cards?

On Sana Biotechnology's Q4 2024 earnings call, investors can expect updates regarding the developmental programs for its clinical-stage candidates.

Zacks last month

SANA
+15.03%
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the Cowen 45th Annual Health Care Conference at 3:10 p.m. ET on Monday, March 3, 2025. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations page of San

GlobeNewswire last month

SANA
+15.03%
Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor

As the S&P 500 flirts with record highs and major indexes post weekly gains, investors are keenly observing market dynamics to identify potential opportunities. Penny stocks, despite their somewhat outdated moniker, continue to attract attention for their potential value and growth prospects. Typically representing smaller or newer companies, these stocks can offer unique opportunities for growth at lower price points when backed by strong financials and sound fundamentals.

Simply Wall St. last month

CMRX

MATH

SANA
+15.03%
Sana Biotechnology, Inc. (SANA): A Bull Case Theory

We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In this article, we will summarize the bulls’ thesis on SANA. Sana Biotechnology, Inc. (SANA)’s share was trading at $3.37 as of Jan 27th. Sana Biotechnology (SANA) is revolutionizing cell therapy by addressing one of the most critical challenges in […]

Insider Monkey 2 months ago

SANA
+15.03%
Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025?

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation between $200 million and $20 billion. The definition is pretty […]

Insider Monkey 2 months ago

SANA
+15.03%
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data

Sana stock soars in a week following positive initial data from a first-in-human study of investigational cell therapy, UP421, in diabetes patients.

Zacks 2 months ago

SANA
+15.03%
HALO
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 43rd Annual J.P. Morgan Healthcare Conference at 9:00 a.m. PT on Wednesday, January 15, 2025. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations

GlobeNewswire 3 months ago

SANA
+15.03%
Top Midday Gainers

Sana Biotechnology (SANA) shares more than doubled intraday Wednesday, a day after the company repor

PREMIUM
MT Newswires 3 months ago

SANA
+15.03%
Sana Biotechnology (SANA), eBay (EBAY) Are Among Today’s Big Winners

Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market’s losses. Sana is soaring nearly 250%, while eBay is climbing a much more modest 12%. Sana Reports Upbeat Trial Results Sana announced that its primary islet cell therapy, UP421, had been successfully implanted into a Type 1 diabetes […]

Insider Monkey 3 months ago

SANA
+15.03%
EBAY

META
Sana Biotechnology price target lowered to $7 from $8 at BofA

BofA lowered the firm’s price target on Sana Biotechnology (SANA) to $7 from $8 and keeps a Buy rating on the shares. While political and rate uncertainty continues to be an overhang, the firm views the health of the Biopharma sector as “markedly improved from 2022 lows.” For stocks in its coverage, the firm continues to like late-stage clinical or early launch stories, although it sees Phase 1 clinical programs with derisking data and near-term catalysts as “increasingly areas of investor focus

TipRanks 3 months ago

SANA
+15.03%
Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative reaction to data for its hives drug and Stoke finalized Phase 3 trial plans.

BioPharma Dive 3 months ago

SANA
+15.03%
STOK
+7.67%
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results Demonstrate HIP-Engineered Primary Pancreatic Islet Cells Avoid Immune Detection, Function, and Persist after Intramuscular Transplantation in First Treated Patient with Type 1 Diabetes Function and Persistence of Pancreatic Islets Were Detectable by Production of Consistent Levels of Circulating C-Peptide,

GlobeNewswire 3 months ago

SANA
+15.03%
$Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus$

Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus

Fast Track designation is designed to expedite clinical development and regulatory review timelines Enrolling patients in the GLEAM trial for SC291 in B-cell mediated autoimmune diseases, including systemic lupus erythematosus; expect to report initial clinical data in 2025 SEATTLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that the U.S. Food and Drug Administration

GlobeNewswire 4 months ago

SANA
+15.03%
Sana Biotechnology to Present at December 2024 Investor Conferences

SEATTLE, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in December. The presentations will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. Sana will participate on a panel at Citi’s 2024 Global Healthcare Conference at 2:30 p.m. ET on Tuesday, December 3

GlobeNewswire 4 months ago

SANA
+15.03%
Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher

Sana (SANA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Zacks 4 months ago

SANA
+15.03%

Performance Overview

Return	SANA	S&P 500 (^GSPC)
YTD	+7.98%	-8.81%
1-Year	-81.20%	+3.16%
3-Year	-79.75%	+21.55%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sana Biotechnology, Inc. (SANA)

Monogram Technologies And Two More Penny Stocks To Watch

Sana: Q4 Earnings Snapshot

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Is Sana Biotechnology (SANA) Among Jeff Bezos’ Investments in 2025?

Why Sana Biotechnology, Inc. (SANA) is Skyrocketing So Far in 2025

SANA Gears Up to Report Q4 Earnings: What's in the Cards?

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor

Sana Biotechnology, Inc. (SANA): A Bull Case Theory

Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025?

SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Top Midday Gainers

Sana Biotechnology (SANA), eBay (EBAY) Are Among Today’s Big Winners

Sana Biotechnology price target lowered to $7 from $8 at BofA

Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus

Sana Biotechnology to Present at December 2024 Investor Conferences

Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher

Performance Overview